Promoting Influenza Vaccinationamong the Risk Population


  • Yupares Payaprom
  • Wongduan Suwannakeeree


Influenza, Influenza vaccine, Promoting vaccination, Risk population


Influenza remains a major global health problem, although significant progress has been made in the prevention and control of this infection. Influenza vaccine is the most effective methods for prevention of influenza. This vaccine has been shown to reduce the incidence of confirmed influenza, severity of disease, and influenza-related complications. Moreover, influenza vaccination significantly reduces hospitalization and in-hospital mortality among adults with chronic diseases. However, influenza vaccination coverage rates for those at risk of developing influenza-related complications in many countries, including Thailand, do not achieve the target rate set by the WHO. Healthcare workers can play an important role in promoting influenza vaccination for people in the risk groups to reach vaccination target in order to reduce the burden of influenza. Nurses are a vital part of healthcare teams and a risk group for influenza. Therefore, they need to have knowledge about influenza, the vaccine, factors influencing vaccination, and strategies to promote influenza vaccination. These strategies include providing patient educationand information about influenza andvaccine safety, providing more convenient access to vaccination and ensuring the adequacy of vaccine supply, as well asbeing a role model for patients-receiving a flu vaccination. This can help to effectively promote influenza vaccination among risk population.


Download data is not yet available.


กระทรวงสาธารณสุข และสำนักงานหลักประกันสุขภาพ
แห่งชาติ. (2560).แนวทางการดำเนินงานให้
ฤดูกาล พ.ศ. 2560.วันที่ค้นข้อมูล 25 มิถุนายน
2560, จาก
กระทรวงสาธารณสุข. (2560).รายงานโรคในระบบ
เฝ้าระวัง 506 โรคไข้หวัดใหญ่.วันที่ค้นข้อมูล
10 พฤษภาคม 2560,จากhttp://www.boe.moph. boedb/surdata/506wk/y60/d15_2460.pdf
Andrew, M. K., McNeil, S., Merry, H., & Rockwood,
K. (2004). Rates of influenza vaccination in
older adults and factors associated with vaccine
use: a secondary analysis of the Canadian study
of health and aging. BMC Public Health, 4(36),
Blank, P. R., Schwenkglenks, M., &Szucs, T. D. (2009).
Disparities in influenza vaccination coverage
rates by target group in five European countries:
Trends over seven consecutive seasons. Infection
Brunton, C., Weir, R., & Jennings, L. (2005).Knowledge
and attitudes about influenza vaccination
amongst general practitioners, practice nurses,
and peopleaged 65 and over.The New Zealand
Medical Journal, 118, 1-11.
Center for Disease Control and Prevention. (2016a).
Influenza signs and symptoms and the role of
laboratorydiagnostics.Retrieved April 6, 2017,
Center for Disease Control and Prevention.
(2016b).Influenza Vaccination Information for
Health Care Workers.Retrieved June 26, 2017,
Center for Disease Control and Prevention. (2017).
Vaccine Effectiveness-How Well Does the Flu
Vaccine Work?Retrieved June 16, 2017, from
Chen, Y., Yi, Q. L., Wu, J., & Li, F. (2007). Chronic
disease status, self-perceived health and hospital
admissions are important predictors for having
a flu shot in Canada. Vaccine, 25, 7436-7440.
Chiatti, C., Rosa, M.D., Barbadoro, P., Lamura, G.,
Stanislao, F.D., & Prospero, E. (2010).
Socioeconomic determinants of influenza
vaccination among older adultsinItaly. Preventive
Medicine, 51, 332-333.
Dae-Ki, K., &Barun, P. (2013).Tools to detect influenza
virus.Retrieved June 5, 2017, from https://
3635619/ pdf/ymj-54-560.pdf
Endrich, M. M., Blank, P. R., &Szucs, T. D.
(2009).Influenza vaccination uptake and
socioeconomic determinants in eleven European
countries.Vaccine, 27,4018-4024.
Ferguson, N. M., Galvani, A. P., & Bush,
R. M. (2003).Ecological and immunological
determinants of influenza evolution.Nature,
Flannery, B., Chung, J.R., Thaker, S.N., Monto, A.S.,
Martin, E.T., Belongia, E.A., & Fry, A. M.
(2017). Interim estimates of 2016-17 seasonal
influenza vaccine effectiveness-United States.
Morbidity and Mortality Weekly Report
(MMWR), 66(6), 167-171.
Grohskopf, L.A., Sokolow, L.Z., Broder, K.R., Olsen,
S.J., Karron, R.A., Jernigan, D.B., & Bresee,
J.S. (2016). Prevention and control of seasonal
influenza with vaccines: Recommendations of
the Advisory Committee on immunization
practices-United States, 2016-17 Influenza
season. Morbidity and Mortality Weekly Report
(MMWR), 65(5), 1-54.
Jimenez-Garcia, R., Hernandez-Barrera, V., Carrasco-
Garrido, P., Andres, A. L., &Miguel, A. G.
(2009). Predictors of influenza vaccination in
adultswithchronic bronchitis. Respiratory
Medicine, 103, 1518-1525.
Jimenez-Garcia, R., Hernandez-Barrera, V., Andres,
A. L., Jimenez-Trujillo, I., Esteban-Hernandez,
J.,& Carrasco-Garrido, P. (2010). Gender
influence ininfluenza vaccine uptake in Spain:
time trends analysis (1995-2006). Vaccine, 28,
Johansen, H., Sambel, C., & Zhao, W. (2006). Flu shotsnational
and provincial territorial. Health
Reports, 17, 43-48.
Kaiser, L., Wat, C., Mills, T., Mahoney, P., Ward, P.,
& Hayden, F. (2003). Impact of oseltamivir
treatment on influenza-related lower respiratory
tract complications and hospitalizations.
Archives of Internal Medicine, 163, 1667-1672.
Kee, S. Y., Lee, J. S., Cheong, H. J., Chun, B. C., Song,
J. Y., Choi, W. S., …, & Kim, W.J. (2007).
Influenza vaccine coverage rates and perceptions
on vaccination in South Korea.Journal of
Infection, 55, 273-281.
Klein, S.L., &Pekosz, A. (2014).Sex-based biology and
the rational design of influenza vaccination
strategies.Journal of Infectious Disease,
209(Suppl. 3), S114-S119doi: 10.1093/infdis/
Kwon, D.S, Kim K.,&Park S.M. (2016).
Factors associatedwith influenza vaccination
coverage among the elderlyin South Korea:
the Fourth Korean National Health and Nutrition
Examination Survey (KNHANES IV). BMJ
Mayo-Montero, E., Hernandez-Barrera, V., Carrasco-
Garrido, P., Miguel, A. G., & Jimenez- Garcia,
R. (2007). Influenza vaccination among persons
with chronic respiratory diseases: coverage,
related factors and time-trend, 1993-2001.
Public Health, 121, 113-121.
McIntyre A, Zecevic A, &Diachun L. (2014).Influenza
vaccinations: older adults’ decisionmaking
process. Canadian Journal on Aging, 33, 92-98.
Nagata J.M., HernแndezRamos, I., Kurup A.S., Albrecht
D., VivasTorrealba, C., & FrancoParedes, C.
(2013). Social determinants of health and
seasonal influenzavaccination in adultse”
65 years: a systematic review of qualitative and
quantitative data. BMC Public Health, 13: 388.
Palache, A., Oriol-Mathieu, V., Fino, M., &Xydia-
Charmanta, M. (2015). Seasonal influenza
vaccine dose distribution in 195 countries (2004-
2013): Little progress in estimated global
vaccination coverage. Vaccine, 33, 5598-5605.
Rothberg, M. B., Haessler, S. D., & Brown, R. B.
(2008).Complications of viral influenza.
The American Journal of Medicine, 121, 258-
Sato, A.P.S., Antunes, J.L.F., Moura, A.R.F., Andrade,
F.B.,Duarte, Y.A.O., &Lebrao, L. (2015).
Factors associated to vaccination against
influenza among elderly in a large Brazilian
metropolis. PLOS ONE.
Stephenson, I., &Zambon, M. (2002).The epidemiology
of influenza.Occupational Medicine, 52(5),
Tabbarah, M., Zimmerman, R., Nowalk, M. P., Janosky,
J. E., Troy, J. A., Raymund, M., & Jewell, I. K.
(2005). What predicts influenza vaccination
status in older Americans over several years?
Journal of American Geriatrics Society, 53,
Telford, R., & Rogers, A. (2003). What influences
elderly peoples’decisions about whether to
accept the influenza vaccination? a qualitative
study. HealthEducation Research, 18, 743-753.
Udell, J.A., Zawi, R., Bhatt, D.L., Keshtkar-Jahronmi,
M., Gaughran, F., Phrommintikul, A.,…,&
Cannon, C. P. (2013). Association between
influenza vaccination and cardiovascular
outcomes in high-risk patients: a meta-analysis.
The Journal of the American Medical Association,
310 (16), 1711-1720.
Vamos, E.P., Pape, U.J., Curcin, V., Harris, M.J.,
Valabhii, J., Majeed, A.,…, &Millett, C. (2016).
Effectiveness of the influenza vaccine in
preventing admission to hospital and death
in people with type 2 diabetes. Canadian
Medical Association Journal. Advance online
publication July 25, 2016.doi:10.1503/cmaj.
Vellozzi, C., Burwen, D.R., Dobardzic, A., Ball, R.,
Walton, K., & Haber, P. (2009). Safety of
trivalent inactivated influenza vaccines in
adults: background for pandemic influenza
vaccine safety monitoring. Vaccine, 27(15),
World Health Organization.(2016). Influenza
(Seasonal). Retrieved May 2, 2017, from
fs211/en/World Health Organization. (2017a).
Biologicals.Retrieved September 7, 2017,
World Health Organization.(2017b). Influenza.
Retrieved June 22, 2017, from http://www.
World Health Organization. (2017c). WHO
recommendations on the composition of
influenza virus vaccines. Retrieved May 12,
2017, from




How to Cite

Payaprom, Y., & Suwannakeeree, W. (2018). Promoting Influenza Vaccinationamong the Risk Population. NU Journal of Nursing and Health Sciences, 12(1S), 13–23. Retrieved from